Suzuki, K., Tsujiguchi, H., Hara, A., Takeshita, Y., Goto, H., Nakano, Y., . . . Takamura, T. Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population. Wiley.
Chicago Style (17th ed.) CitationSuzuki, Keita, et al. Hepatokine Leukocyte Cell‐derived Chemotaxin 2 as a Biomarker of Insulin Resistance, Liver Enzymes, and Metabolic Dysfunction‐associated Steatotic Liver Disease in the General Population. Wiley.
MLA (9th ed.) CitationSuzuki, Keita, et al. Hepatokine Leukocyte Cell‐derived Chemotaxin 2 as a Biomarker of Insulin Resistance, Liver Enzymes, and Metabolic Dysfunction‐associated Steatotic Liver Disease in the General Population. Wiley.